09-May-2021: Links to recent Broker Reports:
04-May-2021: Nova Eye Medical (EYE), Taylor Collison, Update, Outperform
07-May-2021: OreCorp (ORR), Canaccord, Update, (Spec) BUY
29-Apr-2021: Skyfii Limited (SKF), Canaccord, Update, BUY
30-Apr-2021: PainChek (PCK), Canaccord, Update, (Spec) BUY
19-Apr-2021: Smartpay (SMP), CCZ Statton, Update, BUY
01-Apr-2021: Calix Ltd (CXL), Canaccord, Update, BUY
14-Apr-2021: Aerometrex (AMX), Taylor Collison, Update, Outperform
14-Apr-2021: Skyfii Limited (SKF), Canaccord, Update, BUY
16-Apr-2021: Viva Leisure (VVA), Moelis Australia, Initiation, BUY
07-Apr-2021: Artemis Resources (ARV), Taylor Collison, Update, (Spec) BUY
16-Mar-2021: Capral Limited (CAA), Taylor Collison, Update, Outperform
25-Mar-2021: RPMGlobal (RUL), CCZ Statton, Initiation, BUY
24-Mar-2021: Aspen Group (APZ), Taylor Collison, Update, Outperform
18-Mar-2021: 5G Networks Limited (5GN), Wilsons, Update, Overweight
Warning: These are from brokers who are sometimes service providers to the companies they are covering. Often when they are bullish on a company you will find the broker has recently done a CR (capital raising, placement) for that company or were involved in the IPO, or the analyst(s) is/are shareholders. This info is often included in the smallprint in these reports. Always do your own research (DYOR) and remember that these reports simply reflect the views of the authors (analysts), and they could be wrong.
Disclosure: Of the companies who have links to broker reports listed above, I hold none of them, and I only have RUL (RPMGlobal) as a small position in my Strawman.com virtual portfolio. Of the companies who have links to broker reports listed below, I hold all of them, and they are all also in my Strawman.com virtual portfolio.
27-Apr-2021: Canaccord Genuity: Genex Power (GNX): "Sole survivor - the last ASX-listed, Australia-focused renewable player" CG have upgraded GNX from a Spec Buy to a Buy and have maintained their $0.36/share PT (price target).
20-Apr-2021: Ord Minnett: Genex Power (GNX): "Financial close finally in sight" (Buy, $0.29 PT)
18-Apr-2021: Morgans: Genex Power (GNX): "Coffee is for closers so come get a cup" Morgans have upgraded GNX from a Spec Buy to "Add" with a $0.34 PT.
23-Mar-2021: Euroz Hartleys: Research Note: Genex Power (GNX), Buy, $0.35 PT
Note: To give those reports some context, on April 29th (after all three of those reports on GNX were published), Genex announced that at their 29-Apr-2021 EGM the $25M investment by J-POWER (their Japanese cornerstone investor) for K2-Hydro had been approved and that the agreement between Genex Power & J-POWER was now unconditional, and that Financial Close for K2-Hydro was scheduled to occur on 19 May 2021. They had previously announced Project Document Contractual Close (on 31-Mar-2021), Finance Document Contractual Close (on 15-Apr-2021), and the start of construction (on 28-Apr-2021).
GNX has a portfolio of renewable energy generation assets all on the east coast of Australia, including two solar farms that are already operational and producing electricity, and their K2-Hydro pumped storage hydroelectricity (PSH) project is now proceeding. They also have a large-scale battery project and a wind farm that they are going to construct, as well as a much larger solar farm at Kidston in Far-North Queensland that is going to provide electricity to be stored using their K2-Hydro PSH project. A very exciting company in my view and I'm a happy shareholder - having bought in at an average price of 20.5 cents/share, only half a cent higher than their recent capital raising price. It was pleasing to see that Genex have managed to secure funding to allow them to own 100% of K2-Hydro, rather than take on a partner (form a JV) as they had previously indicated they might do - which would have dilluted the upside of the project for existing GNX shareholders. They have the Queensland and the Australian Federal Governments both on board with this project, they have Japanese clean energy company J-POWER as cornerstone investors (in Genex the company rather than in the K2-Hydro project specifically) and they have managed to secure K2-Hydro funding without having to sell a stake in the project to anybody else. That's a big tick for GNX's management in my opinion.
16-Mar-2021: Shaw and Partners: SRG Global (SRG): Rating: Buy, Risk: High, Price Target: $0.70
15-Apr-2021: Canaccord Genuity: Ramelius Resources (RMS): "A horse worth backing" (Buy, PT: $2.00)
[I hold RMS, SRG & GNX]